Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ZYME — Zymeworks Inc.

CIK 884546 SAN FRANCISCO, CA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,984,154
-$651,350 QoQ
Shares Held
152,416
-17.7% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ZYME ranks #152 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,984,154 152,416
2026-03-31 $4,635,504 185,124
2025-12-31 $5,816,533 220,909
2025-09-30 $3,302,588 193,360
2025-06-30 $1,558,760 124,204
2025-03-31 $1,591,640 133,639
2024-12-31 $1,922,319 131,306
2024-09-30 $1,666,614 132,798
2024-06-30 $1,124,579 132,148
2024-03-31 $1,320,165 125,491
2023-12-31 $1,303,851 125,491
2023-09-30 $772,630 121,866
2023-06-30 $1,054,321 122,028